Moderna’s stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
Last updated: 2026-03-04 19:10:53 ET
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
In today’s newsletter: senior international correspondent Julian Borger on what next as Iran targets its Gulf neighbours and the conflict escalatesG...
Democrats disturbed by rationale that Trump ordered pre-emptive strikes out of concern about Tehran retaliationIsrael’s determination to attack Iran...
This webinar will take place at 3pm BST on Tuesday 31 March 2026 Register for free here In today’s construction industry, weak connectivity infrastr...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE